Literature DB >> 9070757

Ischemic damage and subsequent proliferation of oligodendrocytes in focal cerebral ischemia.

K Mandai1, M Matsumoto, K Kitagawa, K Matsushita, T Ohtsuki, T Mabuchi, D R Colman, T Kamada, T Yanagihara.   

Abstract

In order to achieve a better understanding of the pathophysiology of ischemic white matter lesions, oligodendrocytic degeneration and subsequent proliferation were examined in the mouse model of middle cerebral artery occlusion. In situ hybridization histochemistry for proteolipid protein messenger RNA was employed as a sensitive and specific marker of oligodendrocytes, and immunohistochemistry for myelin basic protein was used as a compact myelin marker. Immunohistochemistry for microtubule-associated protein 2 and albumin was employed to monitor neuronal degeneration and the breakdown of the blood brain barrier, respectively. In the ischemic core of the caudoputamen, the immunoreactivity for microtubule-associated protein 2 disappeared and massive albumin extravasation occurred several hours after vessel occlusion, while proteolipid protein messenger RNA signals remained relatively strong at this time. The messenger RNA signals began to attenuate 12 h after ischemia and were hardly detectable 24 h after ischemia in the whole ischemic lesion. In situ end-labeling of fragmented DNA showed some cells with proteolipid protein messenger RNAs to have DNA fragmentation at this period. In contrast to proteolipid protein messenger RNA signals, the immunoreactivity for myelin basic protein was detected as long as five days after ischemia. An apparent increase in the cells possessing strong proteolipid protein messenger RNA signals was found five days after ischemia, mainly in the corpus callosum and the cortex bordering the infarcted areas. A double simultaneous procedure with in situ hybridization for proteolipid protein messenger RNA and immunohistochemistry for glial fibrillary acid protein or lectin histochemistry for macrophages/microglia showed proliferating oligodendrocytes to be co-localized with reactive astrocytes and macrophages/microglia. These findings show that oligodendrocytic damage occurred following ischemic neuronal damage and the breakdown of the blood brain barrier, but preceded the breakdown of myelin proteins in the ischemic lesion, that an apoptosis-like process was involved in ischemic oligodendrocytic death, and that surviving oligodendrocytes responded and proliferated in the outer border of the infarcted area.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9070757

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  28 in total

1.  CX3CL1/CX3CR1 Axis Plays a Key Role in Ischemia-Induced Oligodendrocyte Injury via p38MAPK Signaling Pathway.

Authors:  Xiao-Mei Wu; Yong Liu; Zhong-Ming Qian; Qian-Qian Luo; Ya Ke
Journal:  Mol Neurobiol       Date:  2015-07-20       Impact factor: 5.590

2.  Oligodendrocyte degeneration and recovery after focal cerebral ischemia.

Authors:  S R McIver; M Muccigrosso; E R Gonzales; J M Lee; M S Roberts; M S Sands; M P Goldberg
Journal:  Neuroscience       Date:  2010-05-31       Impact factor: 3.590

3.  HUCBCs increase angiopoietin 1 and induce neurorestorative effects after stroke in T1DM rats.

Authors:  Tao Yan; Poornima Venkat; Xinchun Ye; Michael Chopp; Alex Zacharek; Ruizhuo Ning; Yisheng Cui; Cynthia Roberts; Nicole Kuzmin-Nichols; Cyndy Davis Sanberg; Jieli Chen
Journal:  CNS Neurosci Ther       Date:  2014-07-14       Impact factor: 5.243

4.  Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury.

Authors:  Masanori Iwai; R Anne Stetler; Juan Xing; Xiaoming Hu; Yanqin Gao; Wenting Zhang; Jun Chen; Guodong Cao
Journal:  Stroke       Date:  2010-04-01       Impact factor: 7.914

Review 5.  Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair.

Authors:  Wei Cai; Tuo Yang; Huan Liu; Lijuan Han; Kai Zhang; Xiaoming Hu; Xuejing Zhang; Ke-Jie Yin; Yanqin Gao; Michael V L Bennett; Rehana K Leak; Jun Chen
Journal:  Prog Neurobiol       Date:  2017-10-12       Impact factor: 11.685

Review 6.  The Role of the Oligodendrocyte Lineage in Acute Brain Trauma.

Authors:  Anja Scheller; Xianshu Bai; Frank Kirchhoff
Journal:  Neurochem Res       Date:  2017-07-12       Impact factor: 3.996

Review 7.  Subcortical ischemic vascular disease: Roles of oligodendrocyte function in experimental models of subcortical white-matter injury.

Authors:  Akihiro Shindo; Anna C Liang; Takakuni Maki; Nobukazu Miyamoto; Hidekazu Tomimoto; Eng H Lo; Ken Arai
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

8.  Experimental models for analysis of oligodendrocyte pathophysiology in stroke.

Authors:  Ken Arai; Eng H Lo
Journal:  Exp Transl Stroke Med       Date:  2009-10-24

9.  Erythropoietin amplifies stroke-induced oligodendrogenesis in the rat.

Authors:  Li Zhang; Michael Chopp; Rui Lan Zhang; Lei Wang; Jing Zhang; Ying Wang; Yier Toh; Manoranjan Santra; Mei Lu; Zheng Gang Zhang
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

10.  Reversible loss of N-acetylaspartate after 15-min transient middle cerebral artery occlusion in rat: a longitudinal study with in vivo proton magnetic resonance spectroscopy.

Authors:  Junchao Qian; Baojin Qian; Hao Lei
Journal:  Neurochem Res       Date:  2012-10-18       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.